Ranolazine in Patients With Implantable Cardioverter-Defibrillators: Ready for Prime Time?

[Display omitted]

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 72; no. 6; pp. 646 - 649
Main Author Albert, Christine M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 07.08.2018
Elsevier Limited
Subjects
antiarrhythmic drugs
Cardiac arrhythmia
Cardiology
Defibrillators
Defibrillators, Implantable
Electric Countershock
Humans
implantable cardioverter-defibrillator
Mortality
Noncompliance
Patients
Prevention
Quality of life
randomized clinical trial
Ranolazine
Tachycardia, Ventricular
ventricular tachycardia
Canada
United States > US
antiarrhythmic drugs
randomized clinical trial
ventricular tachycardia
implantable cardioverter-defibrillator
Online AccessGet full text

Cover

More Information
Summary:[Display omitted]
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2018.06.008